✨ Your Portfolio is fetched and updated from zerodha.
Micro Pharmaceuticals
Market Cap
₹6 Cr.
P/E
0.00
  • MPS Pharmaa
  • Fabino Enterprises
  • Kobo Biotech
FAQs on MPS Pharmaa Ltd. Shareprice

MPS Pharmaa has given better returns compared to its competitors.
MPS Pharmaa has grown at ~29.65% over the last 3yrs while peers have grown at a median rate of 0.0%

There is insufficient historical data to gauge this.
Latest PE of MPS Pharmaa is 0

Growth Table
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Balance Sheet
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Balance Sheet Snapshot
No data available.
Fund Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
*Data is as of latest FY end
Profit & Loss
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Cash Flow
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Cash Flow Analysis
  • 1y
  • 3y
  • 5y
  • 10y
  • Increase
  • Decrease
  • Total
No data available.
Ratios
= Dominant Factor
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Quarterly Results
  • MPS Pharmaa Ltd.
  • Fabino Enterprises
  • Kobo Biotech
Reverse DCF
locked
Cr
locked
5 YEAR
locked 5
10 YEAR
locked 10
20 YEAR
locked 20
Implied Growth Rate over a 5 year period*
Implied Growth Rate over a 10 year period*
Implied Growth Rate over a 20 year period*
FAQs on MPS Pharmaa Ltd. Financials

MPS Pharmaa balance sheet is weak and might have solvency issues

Yes, The debt of MPS Pharmaa is increasing.
Latest debt of MPS Pharmaa is ₹7.43 Crs as of Sep-24.
This is greater than Mar-24 when it was ₹7.26 Crs.

The profit is oscillating.
The profit of MPS Pharmaa is -₹0.83 Crs for Mar 2024, -₹1.05 Crs for Mar 2023 and -₹0.14 Crs for Mar 2022

The company seems to be paying a very low dividend.
Investors need to see where the company is allocating its profits.
MPS Pharmaa latest dividend payout ratio is 0% and 3yr average dividend payout ratio is 0%

Companies resources are majorly tied in miscellaneous assets

Ideas Dashboard
Timeline
Watchlist
Portfolio
Alerts
Research
Stock Screener
Market
Raw Material
Data feed provided by Accord Fintech